-+ 0.00%
-+ 0.00%
-+ 0.00%

COMPASS THERAPEUTICS INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $4 FROM $11

Reuters·05/06/2026 03:27:10

Please log in to view news